bioAffinity Statistics Share Statistics bioAffinity has 28.46M
shares outstanding. The number of shares has increased by 33.69%
in one year.
Shares Outstanding 28.46M Shares Change (YoY) 33.69% Shares Change (QoQ) 0% Owned by Institutions (%) 4.32% Shares Floating 20.25M Failed to Deliver (FTD) Shares 3,871 FTD / Avg. Volume 0.03%
Short Selling Information The latest short interest is 459.51K, so 1.69% of the outstanding
shares have been sold short.
Short Interest 459.51K Short % of Shares Out 1.69% Short % of Float 1.83% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.22 and the forward
PE ratio is -1.58.
bioAffinity's PEG ratio is
0.06.
PE Ratio -1.22 Forward PE -1.58 PS Ratio 1.18 Forward PS 1 PB Ratio 4.24 P/FCF Ratio -1.5 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for bioAffinity.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.87,
with a Debt / Equity ratio of 0.58.
Current Ratio 0.87 Quick Ratio 0.86 Debt / Equity 0.58 Debt / EBITDA -0.18 Debt / FCF -0.2 Interest Coverage -96.82
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $164.25K Profits Per Employee $-158.59K Employee Count 57 Asset Turnover 1.44 Inventory Turnover 216.73
Taxes Income Tax 11.65K Effective Tax Rate -0.13%
Stock Price Statistics The stock price has increased by -87.83% in the
last 52 weeks. The beta is 2.56, so bioAffinity's
price volatility has been higher than the market average.
Beta 2.56 52-Week Price Change -87.83% 50-Day Moving Average 0.41 200-Day Moving Average 0.96 Relative Strength Index (RSI) 46.47 Average Volume (20 Days) 12,387,958
Income Statement In the last 12 months, bioAffinity had revenue of 9.36M
and earned -9.04M
in profits. Earnings per share was -0.73.
Revenue 9.36M Gross Profit 3.38M Operating Income -8.95M Net Income -9.04M EBITDA -8.33M EBIT -8.94M Earnings Per Share (EPS) -0.73
Full Income Statement Balance Sheet The company has 1.11M in cash and 1.5M in
debt, giving a net cash position of -395.9K.
Cash & Cash Equivalents 1.11M Total Debt 1.5M Net Cash -395.9K Retained Earnings -53.64M Total Assets 5.55M Working Capital -1.55M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.26M
and capital expenditures -79.08K, giving a free cash flow of -7.34M.
Operating Cash Flow -7.26M Capital Expenditures -79.08K Free Cash Flow -7.34M FCF Per Share -0.61
Full Cash Flow Statement Margins Gross margin is 36.09%, with operating and profit margins of -95.64% and -96.56%.
Gross Margin 36.09% Operating Margin -95.64% Pretax Margin -96.43% Profit Margin -96.56% EBITDA Margin -88.98% EBIT Margin -95.64% FCF Margin -78.44%
